Different mechanisms involved in the berberine‐induced antiproliferation effects in triple‐negative breast cancer cell lines

Cancer studies based on secondary data analysis of the Taiwanʼs National Health Insurance Research Database

(2017) Jui-Kun Chiang et al.   MEDICINE

PI3K-AKT-mTOR inhibitors in breast cancers: From tumor cell signaling to clinical trials

(2017) Nandini Dey et al.   PHARMACOLOGY & THERAPEUTICS

Berberine inhibits the proliferation and migration of breast cancer ZR-75-30 cells by targeting Ephrin-B2

(2017) Weina Ma et al.   PHYTOMEDICINE

Berberine enhances the anti-tumor activity of tamoxifen in drug-sensitive MCF-7 and drug-resistant MCF-7/TAM cells

(2016) Chunjie Wen et al.   Molecular Medicine Reports

Recommendations from the INHAND Apoptosis/Necrosis Working Group

(2016) Susan A. Elmore et al.   TOXICOLOGIC PATHOLOGY

In vitro and in vivo inhibition of tumor cell viability by combined dihydroartemisinin and doxorubicin treatment, and the underlying mechanism

(2016) Xiang Tai et al.   Oncology Letters

Docetaxel induced-JNK2/PHD1 signaling pathway increases degradation of HIF-1α and causes cancer cell death under hypoxia

(2016) Eun-Taex Oh et al.   Scientific Reports

Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection

(2016) Brian D. Lehmann et al.   PLoS One

Global Cancer Incidence and Mortality Rates and Trends--An Update

(2015) L. A. Torre et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Berberine Sensitizes Human Ovarian Cancer Cells to Cisplatin Through miR-93/PTEN/Akt Signaling Pathway

(2015) Qiaoyun Chen et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Berberine Regulated Lipid Metabolism in the Presence of C75, Compound C, and TOFA in Breast Cancer Cell Line MCF-7

(2015) Wen Tan et al.   Evidence-based Complementary and Alternative Medicine

Multiple Molecular Subtypes of Triple-Negative Breast Cancer Critically Rely on Androgen Receptor and Respond to Enzalutamide In Vivo

(2015) V. N. Barton et al.   MOLECULAR CANCER THERAPEUTICS

Is the future of personalized therapy in triple-negative breast cancer based on molecular subtype?

(2015) Fanny Le Du et al.   Oncotarget

Evaluation of Synergetic Anticancer Activity of Berberine and Curcumin on Different Models of A549, Hep-G2, MCF-7, Jurkat, and K562 Cell Lines

(2015) Acharya Balakrishna et al.   Biomed Research International

Berberine induces apoptosis via ROS generation in PANC-1 and MIA-PaCa2 pancreatic cell lines

(2014) S.H. Park et al.   BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH

Subtyping of triple-negative breast cancer: Implications for therapy

(2014) Vandana G. Abramson et al.   CANCER

Berberine hydrochloride IL-8 dependently inhibits invasion and IL-8-independently promotes cell apoptosis in MDA-MB-231 cells

(2014) XIANG LI et al.   ONCOLOGY REPORTS

Berberine Suppresses TPA-Induced Fibronectin Expression through the Inhibition of VEGF Secretion in Breast Cancer Cells

(2013) Sangmin Kim et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberine

(2012) William H. Chappell et al.   CELL CYCLE

Berberine, an Isoquinoline Alkaloid, Inhibits the Metastatic Potential of Breast Cancer Cells via Akt Pathway Modulation

(2012) Han-Peng Kuo et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Berberine Induces Caspase-Independent Cell Death in Colon Tumor Cells through Activation of Apoptosis-Inducing Factor

(2012) Lihong Wang et al.   PLoS One

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

(2011) Brian D. Lehmann et al.   JOURNAL OF CLINICAL INVESTIGATION

COX-2 and survivin reduction may play a role in berberine-induced apoptosis in human ductal breast epithelial tumor cell line

(2011) Yaghub Pazhang et al.   TUMOR BIOLOGY

ErbB family receptor inhibitors as therapeutic agents in breast cancer: Current status and future clinical perspective

(2010) Ruchi Saxena et al.   MEDICINAL RESEARCH REVIEWS